Balchem Co. (NASDAQ:BCPC) Shares Sold by Montanaro Asset Management Ltd

Montanaro Asset Management Ltd cut its holdings in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 15.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 107,500 shares of the basic materials company's stock after selling 20,300 shares during the quarter. Balchem comprises 3.6% of Montanaro Asset Management Ltd's investment portfolio, making the stock its 7th largest holding. Montanaro Asset Management Ltd owned approximately 0.33% of Balchem worth $17,522,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Arizona State Retirement System grew its position in Balchem by 0.8% in the fourth quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock valued at $1,534,000 after acquiring an additional 77 shares during the period. Heritage Family Offices LLP lifted its holdings in Balchem by 8.3% during the 4th quarter. Heritage Family Offices LLP now owns 1,420 shares of the basic materials company's stock worth $231,000 after buying an additional 109 shares in the last quarter. Inspire Investing LLC boosted its position in Balchem by 4.9% in the 4th quarter. Inspire Investing LLC now owns 2,462 shares of the basic materials company's stock valued at $401,000 after buying an additional 114 shares during the last quarter. Westside Investment Management Inc. bought a new stake in shares of Balchem during the third quarter worth $27,000. Finally, Inspire Advisors LLC lifted its stake in shares of Balchem by 3.2% during the fourth quarter. Inspire Advisors LLC now owns 5,123 shares of the basic materials company's stock valued at $835,000 after acquiring an additional 161 shares during the period. 87.91% of the stock is owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Sidoti raised shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th. StockNews.com cut Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. Finally, HC Wainwright reissued a "buy" rating and set a $190.00 price objective on shares of Balchem in a research note on Monday, February 24th.

Balchem Stock Up 0.7 %

NASDAQ:BCPC traded up $1.12 during trading hours on Monday, reaching $164.91. 31,090 shares of the stock were exchanged, compared to its average volume of 121,721. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. Balchem Co. has a twelve month low of $137.69 and a twelve month high of $186.03. The stock has a market cap of $5.37 billion, a PE ratio of 5.98, a PEG ratio of 4.41 and a beta of 0.63. The firm has a 50 day moving average of $165.26 and a 200 day moving average of $169.28.

Balchem (NASDAQ:BCPC - Get Free Report) last released its earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The company had revenue of $240.00 million during the quarter, compared to analyst estimates of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. On average, equities analysts expect that Balchem Co. will post 4.64 earnings per share for the current year.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.